Product References and Citations for anti-IgG antibody
1. Takamatsu H, Andersen JK, Denyer MS, Parkhouse RM. Establishment of long-term CD154-dependent porcine B-cell cultures. Immunology. 1999;97:211-8. (ELISA, FC)
2. Hampson DJ, Robertson ID, La T, Oxberry SL, Pethick DW. Influences of diet and vaccination on colonisation of pigs by the intestinal spirochaete Brachyspira (Serpulina) pilosicoli. Vet Microbiol. 2000;73:75-84. (ELISA)
3. La T, Phillips ND, Reichel MP, Hampson DJ. Protection of pigs from swine dysentery by vaccination with recombinant BmpB, a 29.7 kDa outer-membrane lipoprotein of Brachyspira hyodysenteriae. Vet Microbiol. 2004;102:97-109. (ELISA)
4. Linghua Z, Xingshan T, Fengzhen Z. The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo. Int Immunopharmacol. 2006;6:1267-76. (ELISA)
5. Linghua Z, Yong G, Xingshan T, Fengzhen Z. CpG oligodinucleotides induce strong humoral and cellular responses to swine streptococcic septicemia vaccine in piglets in vivo. Int Immunopharmacol. 2006;6:342-50. (ELISA)
6. Yao Q, Qian P, Huang Q, Cao Y, Chen H. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs. J Virol Methods. 2008;147:143-50. (ELISA, WB)
7. Zhou M, Guo Y, Zhao J, Hu Q, Hu Y, Zhang A, et al. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5. Vaccine. 2009;27:5271-7. (ELISA, WB)
8. La T, Phillips ND, Hampson DJ. Evaluation of recombinant Bhlp29.7 as an ELISA antigen for detecting pig herds with swine dysentery. Vet Microbiol. 2009;133:98-104. (ELISA)
9. Li J, Xia J, Tan C, Zhou Y, Wang Y, Zheng C, et al. Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2. Vaccine. 2011;29:6514-9. (ELISA, WB)
10. Fu S, Zhang M, Xu J, Ou J, Wang Y, Liu H, et al. Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins. Vaccine. 2013;31:347-53. (ELISA)